Companies: 10,795·Total market cap: $144.5T
OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc.

OVITOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2356
P/E Ratio—
52W High$0.0004
52W Low$0.0001
SEC Filings

OncoVista Innovative Therapies, Inc. (OVIT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001094847 · OVIT · OTC · as of Jun 9, 2026

Filing snapshot

205
Total Filings
15-12G
Latest Form
2016-05-09
Most Recent
2007
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001094847 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2015-04-15
Fiscal Year End
Apr 15, 2015
Accession No.
0001144204-15-022873
Primary Document
v406669_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001094847 · Accession 0001144204-15-022873

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2015-11-12
View 10-Q on SEC
8-KCurrent Report
Current Report
2011-03-10Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2016-05-09
View
SC 13GBeneficial Ownership Report
NONE
2016-04-27
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2016-04-08
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2016-02-04
View
10-QQuarterly Report
FORM 10-Q
2015-11-12
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2015-09-08
View
10-QQuarterly Report
FORM 10-Q
2015-08-14
View
10-QQuarterly Report
FORM 10-Q
2015-05-15
View
10-KAnnual Report
10-K
2015-04-15
View
NT 10-KNT 10-K
NT 10-K
2015-03-23
View
SC 13G/ABeneficial Ownership Report (Amended)
WEXFORD CAPITAL LP SC 13G A2 1-12-15
2015-01-12
View
10-QQuarterly Report
10-Q
2014-11-13
View
10-QQuarterly Report
10-Q
2014-08-12
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2014-06-19
View
10-QQuarterly Report
10-Q
2014-05-09
View
Showing 1–15 of 194 filingsForm 4 / 144 hidden· 205 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001094847  |  Exchange: OTC · Healthcare

OncoVista Innovative Therapies, Inc. (OTC: OVIT) has submitted 205 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2007. As a Healthcare sector company with CIK 0001094847, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is OncoVista Innovative Therapies, Inc.'s most comprehensive regulatory disclosure. The most recent OncoVista Innovative Therapies, Inc. 10-K was filed on 2015-04-15 for fiscal year ending 2015. Historical OVIT 10-K annual reports are available from 1999 through 2015.

Investors researching OncoVista Innovative Therapies, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ANTH SEC Filings →ONBI SEC Filings →SYVC SEC Filings →NTII SEC Filings →PAOG SEC Filings →LPTI SEC Filings →RGMP SEC Filings →COTQF SEC Filings →
→ OVIT Financials→ OVIT Earnings→ OVIT Insider Trades

Frequently Asked Questions

OVIT SEC Filings · 8 questions

OncoVista Innovative Therapies, Inc. (OVIT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 205 filings and access original documents at no cost. OncoVista Innovative Therapies, Inc.'s CIK is 0001094847.

OVIT SEC filingsOncoVista Innovative Therapies, Inc. SEC documentsfind OVIT 10-K